| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jan―20 |
Telerehabilitation in patients with long COVID-19 syndrome |
Shige Li, Wenbo Dong, Bing Dai, Wei Wang, Wei Tan |
| 2 |
[GO] |
2024―Nov―09 |
Hypertension management: The lesson from the SARS-CoV-2 pandemic |
Lanfranco D'Elia |
| 3 |
[GO] |
2024―Sep―10 |
The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study) |
Aleksandra Ostrowska, Wiktoria Wojciechowska, Marek Rajzer, Thomas Weber, Michael Bursztyn, Alexandre Persu, George Stergiou, Grzegorz Kiełbasa, Marzena Chrostowska, Michaelis Doumas, Gianfranco Parati, Grzegorz Bilo, Guido Grassi, Giuseppe Mancia, Andrzej Januszewicz, Reinhold Kreutz, Krzysztof Narkiewicz, Andżelina Dubiela, Konstantinos Imprialos, Konstantinos Stavropoulos, Jean-Baptiste de Freminville, Michel Azizi, Pedro Guimarães Cunha, Jacek Lewandowski, Jakub Strzelczyk, Gregoire Wuerzner, Maria Gosk-Przybyłek, Elżbieta Szwęch, Aleksander Prejbisz, Patricia Van der Niepen, Thomas Kahan, Andreas Jekell, Jonas Spaak, Konstantinos Tsioufis, Georg Ehret, Adrian Doroszko, Piotr Kubalski, Jorge Polonia, Katarzyna Styczkiewicz, Marek Styczkiewicz, Stanisław Mazur, Franco Veglio, Franco Rabbia, Elisabetta Eula, Fernando Jaen Águila, Riccardo Sarzani, Francesco Spannella, Zoltan Jarai, Dimitrios Papadopoulos, Marilucy Lopez - Sublet, Charalampos Grassos, Ioannis Kahrimanidis, Eugenia Gkaliagkousi, Areti Triantafyllou, Tomasz Grodzicki, Barbara Wizner, Aleksandra Seweryn, Beata Moczulska, Angeliki Ntineri, Nicolas Roberto Robles, Jiri Widmiski, Edyta Zbroch |
| 4 |
[GO] |
2024―Aug―24 |
DNA methylation levels of the ACE2 promoter are not associated with symptoms-severity and related-disability in previously hospitalized COVID-19 survivors |
César Fernández-de-las-Peñas, Gema Díaz-Gil, Antonio Gil-Crujera, Stella M. Gómez-Sánchez, Silvia Ambite-Quesada |
| 5 |
[GO] |
2024―Jul―08 |
Autonomic dysfunction in post-acute sequelae of COVID-19 |
Marie-Claire Seeley, Howard O'Brien, Celine Gallagher, Caelum Schild, Dennis H. Lau |
| 6 |
[GO] |
2024―May―28 |
Dual tobacco smoking, electronic cigarette use and COVID-19 outcomes |
Tahlia Grammatopoulos, Ellana Yeoh, Nouhad El-Haddad, Kristin Carson-Chahhoud, Freddy Sitas |
| 7 |
[GO] |
2024―Mar―11 |
Risk prediction of major cardiac adverse events and all-cause death following covid-19 hospitalization at one year follow-up: The HOPE-2 score |
Francesco Santoro, Ivan J. Núñez-Gil, María C. Viana-Llamas, Emilio Alfonso-Rodríguez, Aitor Uribarri, Victor Manuel Becerra-Muñoz, Gisela Feltes Guzman, Nicola Di Nunno, Javier Lopez-Pais, Enrico Cerrato, Gianfranco Sinagra, Massimo Mapelli, Riccardo M. Inciardi, Claudia Specchia, Chiara Oriecuia, Natale Daniele Brunetti |
| 8 |
[GO] |
2024―Mar―08 |
Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm |
Panagiotis G. Asteris, Amir H. Gandomi, Danial J. Armaghani, Styliani Kokoris, Anastasia T. Papandreadi, Anna Roumelioti, Stefanos Papanikolaou, Markos Z. Tsoukalas, Leonidas Triantafyllidis, Evangelos I. Koutras, Abidhan Bardhan, Ahmed Salih Mohammed, Hosein Naderpour, Satish Paudel, Pijush Samui, Ioannis Ntanasis-Stathopoulos, Meletios A. Dimopoulos, Evangelos Terpos |
| 9 |
[GO] |
2024―Feb―07 |
Prevalence of post-COVID symptoms one-year after SARS-CoV-2 infection in patients with interstitial lung disease |
Paula Parás-Bravo, César Fernández-de-las-Peñas, Diego Ferrer-Pargada, Sheila Izquierdo-Cuervo, Manuel Herrero-Montes |
| 10 |
[GO] |
2024―Feb―02 |
Longitudinal trends in acute pulmonary embolism hospitalizations during the COVID-19 pandemic |
Agam Bansal, Aravinda Nanjundappa, Daniel Raymond, Lee Kirksey, Umesh N. Khot |
| 11 |
[GO] |
2024―Jan―28 |
Osteonecrosis risk after steroids-related treatment of COVID-19 is not negligible: A cross sectional study |
Antonios A. Koutalos, Alexandros Koskiniotis, Christos Rountas, Efstathios Konstantinou, Sarah Georgiadou, Aggelos Stefos, Nikolaos K. Gatselis, George N. Dalekos, Konstantinos N. Malizos |
| 12 |
[GO] |
2024―Jan―05 |
The role of novel nicotine-containing products on SARS-CoV-2 infection and COVID-19 progression |
Marco Scala, Alessandra Lugo, Giansanto Mosconi, Antonella Zambon, Anna Odone, Luc Smits, Silvano Gallus |
| 13 |
[GO] |
2023―Dec―20 |
Thyroid and adrenal incidentalomas on chest CT: Prevalence, diagnostic work-up and outcomes in a cohort of COVID-19 suspected patients |
Jeresa I.A. Willems, Roderick F.A. Tummers-de Lind van Wijngaarden, Ivo J.M. Dubelaar, Martijn D. De Kruif, Math P.G. Leers, Inge H.Y. Luu, Robin P. Peeters, Daan J.L. van Twist |
| 14 |
[GO] |
2023―Dec―09 |
Prognosis of hospitalized patients during different pandemic waves in Greece: Omicron innocent until proven guilty? |
Ioannis El. Michelakis, Aristeidis E. Boukouris, Anastasia Komodromou, Stefania Foteinou, Maria Dafni |
| 15 |
[GO] |
2023―Dec―05 |
Long COVID autonomic syndrome: Improved understanding through translational research |
James Quinn |
| 16 |
[GO] |
2023―Dec―02 |
Impact of rehabilitation treatment during the acute phase of SARS-CoV-2 infection |
Ugo Paliani, Andrea Cardona, Alessio Gili, Maria Laura Di Meo, Maria La Penna |
| 17 |
[GO] |
2023―Nov―11 |
Calprotectin serum levels on admission and during follow-up predict severity and outcome of patients with COVID-19: A prospective study |
Nikolaos K. Gatselis, Aggeliki Lyberopoulou, Vasiliki Lygoura, George Giannoulis, Anna Samakidou, Antonia Vaiou, Katerina Antoniou, Katerina Triantafyllou, Aggelos Stefos, Sarah Georgiadou, Dimitrios Sagris, Dafni Sveroni, Stella Gabeta, George Ntaios, Gary L. Norman, George N. Dalekos |
| 18 |
[GO] |
2023―Oct―28 |
Prevalence, predictors and outcomes of physician care left undone in acute care hospitals across six European countries during COVID-19: A cross-sectional study |
Simon Dello, Luk Bruyneel, Dorothea Kohnen, Hans De Witte, Wilmar B. Schaufeli, Matthew D. Mchugh, Linda H. Aiken, Walter Sermeus |
| 19 |
[GO] |
2023―Oct―25 |
Newer COVID-19 vaccines: Still lights and shadows? |
Fabio Angeli, Martina Zappa, Paolo Verdecchia |
| 20 |
[GO] |
2023―Oct―16 |
Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection |
Fabio Angeli, Martina Zappa, Paolo Verdecchia |
| 21 |
[GO] |
2023―Oct―07 |
Cost-effectiveness analysis of ritonavir boosted nirmatrelvir for adult outpatients with mild to moderate COVID-19 in a European health system |
Philip Wikman-Jorgensen, José María Ibarra, Carlos Devesa, Jorge Peris, Jara Llenas-García |
| 22 |
[GO] |
2023―Oct―05 |
Causes of death in nursing home residents during the pandemic |
Ugo Fedeli, Marco Braggion, Silvia Pierobon, Claudio Barbiellini Amidei, Manuel Zorzi |
| 23 |
[GO] |
2023―Sep―29 |
The peculiarities of COVID-19 in older people: Considerations after two years |
Caterina Trevisan, Chukwuma Okoye, Raffaele Antonelli Incalzi |
| 24 |
[GO] |
2023―Sep―29 |
Chronic liver disease-related mortality during the COVID-19 pandemic |
Donghee Kim, Richie Manikat, Karn Wijarnpreecha, George Cholankeril, Aijaz Ahmed |
| 25 |
[GO] |
2023―Sep―16 |
CHEDDAR score versus YEARS algorithm for suspected pulmonary embolism in SARS-CoV-2-infected patients: A comparison of two strategies |
Anabel Franco-Moreno, Aida Izquierdo-Martínez, Idoia Pagai-Valcárcel, Juan Torres-Macho, Cristina Lucía de Ancos-Aracil |
| 26 |
[GO] |
2023―Sep―09 |
The old and the new: The EG.5 (‘Eris’) sub-variant of Coronavirus |
Martina Zappa, Paolo Verdecchia, Andrea Andolina, Fabio Angeli |
| 27 |
[GO] |
2023―Aug―12 |
Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults |
Loreto Vidaur, Itziar Eguibar, Ander Olazabal, Maialen Aseguinolaza, Oihana Leizaola, Amalur Guridi, Maria Teresa Iglesias, Jordi Rello |
| 28 |
[GO] |
2023―Aug―03 |
Immune regulators for the treatment of COVID-19: A critical appraisal after two years |
Nicola Farina, Lorenzo Dagna |
| 29 |
[GO] |
2023―Jul―27 |
COVID-19 research waste: An analysis on terminated clinical trials on medicines on ClinicalTrials.gov |
Rafael Dal-Ré |
| 30 |
[GO] |
2023―Jul―14 |
Persistently raised blood pressure following coronavirus disease 2019 vaccines: Implication for future systematic research and monitoring |
Samadhi Patamatamkul, Maythinee Potongcamphan |
| 31 |
[GO] |
2023―Jul―08 |
Prevalence and characteristics of post COVID-19 condition five months after SARS-COV-2 infection in inpatients and outpatients. |
Ivonne Chong, Jan A. Roth, Balthasar L Hug |
| 32 |
[GO] |
2023―Jun―28 |
The efficacy and safety of out-hospital anticoagulation therapy with direct oral anticoagulant for COVID-19 |
Yu Geng, Chang Meng, Tong Gao, Ping Zhang, Yintang Wang |
| 33 |
[GO] |
2023―Jun―16 |
Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases |
Mai Kawazoe, Junko Nishio, Wataru Hirose, Karin Furukawa, Toshihiro Nanki |
| 34 |
[GO] |
2023―Jun―02 |
Understanding the biological success of SARS-CoV-2: Immunoevasion strategies and beyond |
Giuseppe Lippi, Brandon M. Henry |
| 35 |
[GO] |
2023―May―28 |
Impact of the covid-19 pandemic on the occurrence and outcome of cardiogenic shock complicating acute myocardial infarction |
Zuzana Motovska, Ota Hlinomaz, Jan Mrozek, Petr Kala, Jiri Jarkovsky |
| 36 |
[GO] |
2023―May―25 |
Characteristics and Outcomes of COVID-19-Associated Pulmonary Embolism |
Ramy Sedhom, Amr Mohsen, Liset Stoletniy, Dmitry Abramov, Islam Y. Elgendy |
| 37 |
[GO] |
2023―May―24 |
COVID-19 and smoking: considerations after two years |
Giuseppe Lippi, Brandon Michael Henry, Fabian Sanchis-Gomar |
| 38 |
[GO] |
2023―May―22 |
Ocular surface manifestations and SARS-CoV-2 RNA detection in conjunctival swabs of patients hospitalized for COVID-19 pneumonia |
Zsuzsanna Valyi, Maria Khalil, Sigi Van den Wijngaert, François Willermain, Marie Bruyneel |
| 39 |
[GO] |
2023―May―15 |
Characteristics and clinical outcomes of patients with COVID-19 recurrent infection during the omicron variant predominance |
Ran Abuhasira, Nitzan Burrack, Lior Nesher, Daniel Ostrovsky, Victor Novack |
| 40 |
[GO] |
2023―Apr―28 |
Hypertension and myocarditis following COVID-19 vaccination. Two sides of the coin? |
Fabio Angeli, Gianpaolo Reboldi, Martina Zappa, Paolo Verdecchia |
| 41 |
[GO] |
2023―Apr―19 |
Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16 |
Martina Zappa, Paolo Verdecchia, Fabio Angeli |
| 42 |
[GO] |
2023―Apr―10 |
Safety of COVID-19 vaccines |
Rasi Virginia, Rasi Guido |
| 43 |
[GO] |
2023―Mar―30 |
COVID-19 vaccines and increased blood pressure |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 44 |
[GO] |
2023―Mar―29 |
Severe acute respiratory syndrome coronavirus 2 evolution: How mutations affect XBB.1.5 variant |
Martina Zappa, Paolo Verdecchia, Fabio Angeli |
| 45 |
[GO] |
2023―Mar―22 |
Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter |
Alfredo Jose Pardo-Cabello, Victoria Manzano-Gamero, Juan de Dios Luna |
| 46 |
[GO] |
2023―Mar―21 |
Clinical pearls and pitfalls of SARS-CoV-2 serology |
Giuseppe Lippi, Brandon M. Henry |
| 47 |
[GO] |
2023―Mar―06 |
The relationship between COVID-19 vaccines and increased blood pressure: a word of caution |
Giacomo Buso, Claudia Agabiti-Rosei, Maria Lorenza Muiesan |
| 48 |
[GO] |
2023―Feb―20 |
Lung ultrasound must be the first-line image technique in COVID-19 patients |
Juan Torres-Macho, Miguel Angel Casado-Suela, Mercedes Duffort-Falcó |
| 49 |
[GO] |
2023―Feb―17 |
Intravenous pulse methylprednisolone for the treatment of severe COVID-19 |
Dimitrios Patoulias, Athina Dimosiari |
| 50 |
[GO] |
2023―Feb―16 |
Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19) |
Mohammed I. Danjuma, Ridhima Kaul, Tamader Alyaarabi, Basant Elsayed, Mohamed Elshafei |
| 51 |
[GO] |
2023―Feb―13 |
Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
Alfredo Jose Pardo-Cabello, Victoria Manzano-Gamero, Juan de Dios Luna |
| 52 |
[GO] |
2023―Feb―09 |
Evolution of the SARS-CoV-2 epidemic: From genomic surveillance to new health needs |
Andrea Giacomelli, Anna Lisa Ridolfo, Letizia Oreni, Giuliano Rizzardini, Spinello Antinori |
| 53 |
[GO] |
2023―Jan―25 |
The impact of atrial fibrillation on outcomes in patients hospitalized with COVID-19 |
Siddharth Agarwal, Muhammad Bilal Munir, Stavros Stavrakis, Jonathan P Piccini, Zain Ul Abideen Asad |
| 54 |
[GO] |
2023―Jan―05 |
Outcomes of Patients with Cardiac Arrest with and without COVID-19 in the United States |
Agam Bansal, Mohammed Faisaluddin, Raunak Nair, Siddharth Agarwal |
| 55 |
[GO] |
2023―Jan―05 |
Characteristics and outcomes of unvaccinated and vaccinated COVID-19 patients with acute respiratory failure treated with CPAP in a medical intermediate care unit |
Silvia Accordino, Ciro Canetta, Francesco Blasi |
| 56 |
[GO] |
2022―Dec―27 |
Serological testing for SARS-CoV-2: Advancements and future challenges |
Harry Alexopoulos, Ioannis P Trougakos, Meletios-Athanasios Dimopoulos, Evangelos Terpos |
| 57 |
[GO] |
2022―Dec―16 |
Timeline analysis of clinical severity of COVID-19 in the general population |
Camilla Mattiuzzi, Giuseppe Lippi |
| 58 |
[GO] |
2022―Dec―13 |
The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure |
Fabio Angeli, Martina Zappa, Gianpaolo Reboldi, Giorgio Gentile, Monica Trapasso, Antonio Spanevello, Paolo Verdecchia |
| 59 |
[GO] |
2022―Dec―08 |
Long-term lung ultrasound follow-up in patients after COVID-19 pneumonia hospitalization: a prospective comparative study with chest computed tomography |
Greta Barbieri, Luna Gargani, Vittoria Lepri, Stefano Spinelli, Chiara Romei, Annalisa De Liperi, Davide Chimera, Francesco Pistelli, Laura Carrozzi, Francesco Corradi, Lorenzo Ghiadoni |
| 60 |
[GO] |
2022―Dec―05 |
Trend in the proportion of subjects with SARS-CoV-2 infection without COVID-19 specific symptoms among patients admitted to a COVID-19 referral hospital |
Andrea Giacomelli, Anna Lisa Ridolfo, Letizia Oreni, Giuliano Rizzardini, Spinello Antinori |
| 61 |
[GO] |
2022―Dec―02 |
Lack of efficacy of Interferon β-1a in COVID-19 patients with mild to moderate pneumonia |
Carlo Bosi, Roberto Ferrarese, Rebecca De Lorenzo, Nicasio Mancini, Emanuele Bosi |
| 62 |
[GO] |
2022―Nov―30 |
Reshaping care in the aftermath of the pandemic. Implications for cardiology health systems |
Antonio Jordan-Rios, Vincenzo Nuzzi, Daniel I Bromage, Theresa McDonagh, Gianfranco Sinagra, Antonio Cannata |
| 63 |
[GO] |
2022―Nov―23 |
Aspirin and P2Y12 inhibitors in treating COVID-19 |
Amirmohammad Khalaji, Amir Hossein Behnoush, Soheil Peiman |
| 64 |
[GO] |
2022―Nov―23 |
Reliability of SARS-CoV-2 serological testing for influencing public health policies: A reappraisal |
Giuseppe Lippi, Mario Plebani |
| 65 |
[GO] |
2022―Nov―17 |
Hypertension and mortality in SARS-COV-2 infection: A meta-analysis of observational studies after 2 years of pandemic |
Lanfranco D'Elia, Alfonso Giaquinto, Aquilino Flavio Zarrella, Domenico Rendina, Paola Iaccarino Idelson, Pasquale Strazzullo, Ferruccio Galletti |
| 66 |
[GO] |
2022―Nov―16 |
Safety and efficacy of interleukin-1 antagonists in hospitalized patients with COVID-19. |
Athina Dimosiari, Dimitrios Patoulias, Ioannis Pantazopoulos, Epaminondas Zakynthinos, Demosthenes Makris |
| 67 |
[GO] |
2022―Nov―10 |
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies |
Harry Alexopoulos, Ioannis P Trougakos, Meletios-Athanasios Dimopoulos, Evangelos Terpos |
| 68 |
[GO] |
2022―Nov―07 |
The new phase of pandemic: Are BA.2.75 and BQ.1 competitive variants? An in silico evaluation |
Martina Zappa, Paolo Verdecchia, Fabio Angeli |
| 69 |
[GO] |
2022―Oct―31 |
Treatment with COLchicine in hospitalized patients affected by COVID-19: the COLVID-19 trial |
Carlo Perricone, Mirko Scarsi, Antonio Brucato, Paola Pisano, Erika Pigatto, Cecilia Becattini, Antonella Cingolani, Francesco Tiso, Roberto Prota, Lina Rachele Tomasoni, Maurizio Cutolo, Marika Tardella, Davide Rozza, Carlo Zerbino, Massimo Andreoni, Venerino Poletti, Elena Bartoloni, Roberto Gerli, Giacomo Cafaro, Monia Mendeni, Enrico Colombo, Marta Del Medico, Paola Cabras, Mauro Giovanni Schiesaro, Laura Franco, Massimo Fantoni, Lara Friso, Valter Gallo, Franco Franceschini, Sabrina Paolino, Fausto Salaffi, Carlo Scirè, Anna Zanetti, Claudia Diana, Angelina Passaro, Rosario Foti, Francesco Saverio Serino, Maurizio Cassol, Giampaolo Bucaneve, Rosalba Elisabetta Rocchi |
| 70 |
[GO] |
2022―Oct―21 |
Influence of vaccination and immunosuppressive treatments on the coronavirus disease 2019 outcomes in patients with systemic autoimmune diseases |
Jorge Álvarez-Troncoso, Lucía López-Caballero, Ángel Robles-Marhuend, Clara Soto-Abánades, Juan José Ríos-Blanco |
| 71 |
[GO] |
2022―Oct―06 |
Liver injury with autoimmune features after vaccination against SARS-CoV-2: the verdict is still open |
Marco Ferronato, Marco Lenzi, Luigi Muratori |
| 72 |
[GO] |
2022―Oct―03 |
‘Paperdemic’ during the COVID-19 pandemic |
Yang Yang, Na Zhao, Ting Ma, Ze Yuan, Cheng Deng |
| 73 |
[GO] |
2022―Sep―21 |
Corrigendum to ‘External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019’ |
Shermarke Hassan, Chava L. Ramspek, Barbara Ferrari, Merel van Diepen, Raffaella Rossio, Rachel Knevel, Vincenzo la Mura, Andrea Artoni, Ida Martinelli, Alessandra Bandera, Alessandro Nobili, Andrea Gori, Francesco Blasi, Ciro Canetta, Nicola Montano, Frits R. Rosendaal, Flora Peyvandi |
| 74 |
[GO] |
2022―Sep―19 |
Harm of early dexamethasone for COVID-19 and bias in randomized trials |
Isaac Núñez, Yanink Caro-Vega, Adrian Soto-Mota |
| 75 |
[GO] |
2022―Sep―01 |
Non-invasive respiratory supports on inspiratory effort in COVID-19: How and when is it matter of selection? Author's reply. |
Gioacchino Schifino, Maria Laura Vega, Lara Pisani, Stefano Nava |
| 76 |
[GO] |
2022―Aug―24 |
In COVID-19 patients with mild or moderate respiratory failure, duration and type of symptoms influence the diagnostic accuracy of lung ultrasound |
Pawlowska Victoria, Coucke Christophe, Noirez Leslie, Papadimitriou-Olivgeris Matthaios, Monti Matteo |
| 77 |
[GO] |
2022―Aug―23 |
COVID-19 vaccines effect on blood pressure |
Marco Simonini, Maria Giovanna Scarale, Francesca Tunesi, Matteo Moro, Clelia Di Serio, Paolo Manunta, Chiara Lanzani |
| 78 |
[GO] |
2022―Aug―22 |
Non-invasive respiratory supports on inspiratory effort in Covid-19: how and when is it matter of selection? |
Martina Flora, Mariano Mollica, Giuseppe Fiorentino, Antonio M. Esquinas |
| 79 |
[GO] |
2022―Aug―18 |
Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies |
Giuseppe De Luca, Angelo Silverio, Monica Verdoia, Zbigniew Siudak, Tomasz Tokarek, Thomas A. Kite, Anthony H. Gershlick, Oriol Rodriguez-Leor, Belen Cid-Alvarez, Daniel A. Jones, Krishnaraj S. Rathod, José M. Montero-Cabezas, Alfonso Jurado-Roman, Matteo Nardin, Gennaro Galasso |
| 80 |
[GO] |
2022―Aug―16 |
A Reappraisal of Corticosteroids use for COVID-19 |
Ilaria Pati, Francesca Masiello, Simonetta Pupella, Mario Cruciani, Vincenzo De Angelis |
| 81 |
[GO] |
2022―Aug―12 |
Structural evolution of severe acute respiratory syndrome coronavirus 2: implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines |
Martina Zappa, Paolo Verdecchia, Antonio Spanevello, Fabio Angeli |
| 82 |
[GO] |
2022―Aug―01 |
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights |
Raquel Martinez-Reviejo, Sofia Tejada, Ganiyat A.R. Adebanjo, Camilla Chello, Miriam C. Machado, Francesca R. Parisella, Magda Campins, Antonella Tammaro, Jordi Rello |
| 83 |
[GO] |
2022―Jul―18 |
COVID-19 mRNA vaccination in patients with previous myocarditis |
Maurizio Pieroni, Michele Ciabatti, Elisa Saletti, Emanuele D'Aniello, Leonardo Bolognese |
| 84 |
[GO] |
2022―Jul―18 |
The COVID-19 pandemic - How many times were we warned before? |
Naim Mahroum, Isa Seida, Sevval Nil Esirgün, Nicola Luigi Bragazzi |
| 85 |
[GO] |
2022―Jun―28 |
Participants’ informed consent in adaptive, platform drug trials in hospitalized COVID-19 patients: Not all approaches are ethically acceptable |
Rafael Dal-Ré, Arthur L Caplan, Teck Chuan Voo |
| 86 |
[GO] |
2022―Jun―22 |
COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect" |
Fabio Angeli, Gianpaolo Reboldi, Monica Trapasso, Martina Zappa, Antonio Spanevello, Paolo Verdecchia |
| 87 |
[GO] |
2022―Jun―20 |
Durable functional limitation in patients with coronavirus disease-2019 admitted to intensive care and the effect of intermediate-dose vs standard-dose anticoagulation on functional outcomes |
|
| 88 |
[GO] |
2022―Jun―17 |
Supine vs prone position in mild to moderate COVID-19 pneumonia: the impact of proning on computed tomography findings |
S Piciucchi, ML Garo, S Tomassetti, C Ravaglia, V Poletti |
| 89 |
[GO] |
2022―Jun―16 |
Blood pressure increase during hospitalization for COVID-19 |
Fabio Angeli, Martina Zappa, Federico Mattia Oliva, Antonio Spanevello, Paolo Verdecchia |
| 90 |
[GO] |
2022―Jun―09 |
Effects of statins on clinical outcomes in hospitalized patients with COVID-19 |
Paulo Ricardo Martins-Filho, José Augusto Soares Barreto-Filho, Antônio Carlos Sobral Sousa |
| 91 |
[GO] |
2022―Jun―08 |
External validation of risk scores to predict in-hospital mortality in patients hospitalized due to coronavirus disease 2019 |
Shermarke Hassan, Chava L. Ramspek, Barbara Ferrari, Merel van Diepen, Raffaella Rossio, Rachel Knevel, Vincenzo la Mura, Andrea Artoni, Ida Martinelli, Alessandra Bandera, Alessandro Nobili, Andrea Gori, Francesco Blasi, Ciro Canetta, Nicola Montano, Frits R. Rosendaal, Flora Peyvandi |
| 92 |
[GO] |
2022―Jun―06 |
Trends of thrombo-inflammation biomarkers after Tocilizumab predict treatment failure better than scores in patients with severe SARS-CoV2 related respiratory failure |
Luca Masotti, Elisa Cioni, Elisa Grifoni, Francesco Cei, Roberto Tarquini |
| 93 |
[GO] |
2022―Jun―03 |
T-cell immune response predicts the risk of critical SARS-Cov2 infection in hospitalized COVID-19 patients |
Maxime Samson, Barbara Nicolas, Alexandre Guilhem, Hélène Greigert, Marion Ciudad, Claudie Cladiere, Cécile Straub, Mathieu Blot, Lionel Piroth, Thomas Rogier, Hervé Devilliers, Patrick Manckoundia, Thibault Ghesquiere, Stéphanie Francois, Daniela Lakomy, Sylvain Audia, Bernard Bonnotte |
| 94 |
[GO] |
2022―May―30 |
Syndrome of inappropriate antidiuresis as a maladaptive stress response shared by coronavirus disease 2019 and other cytokine storm disorders |
Lorenzo Muccioli, Umberto Pensato, Maria Guarino, Francesca Bisulli, Marco Faustini Fustini |
| 95 |
[GO] |
2022―May―26 |
Personal protective equipment portraits in the era of COVID-19 |
Christopher Hansen-Barkun, Omar Kherad, Adamo A Donovan, Anupa J Prashad, Maida J Sewitch |
| 96 |
[GO] |
2022―May―26 |
The Omicron wave and the waning of COVID-19 vaccine effectiveness. Influence of vaccine booster and age on confirmed infection incidence |
Luis Corral-Gudino, María Piedad Del-Amo-Merino, José María Eiros-Bouza, Jesús Fernando García-Cruces-Méndez, Marta Domínguez-Gil González |
| 97 |
[GO] |
2022―May―25 |
Efficacy and safety of molnupiravir for COVID-19 patients |
Maurish Fatima, Saleha Azeem, Junaid Saeed, Abia Shahid, Huzaifa Ahmad Cheema |
| 98 |
[GO] |
2022―May―12 |
Treatment strategies of Covid-19. A rheumatology perspective. |
Alexandros A. Drosos, Eleftherios Pelechas, Paraskevi V. Voulgari |
| 99 |
[GO] |
2022―Apr―25 |
Interleukin 6 inhibition in severe COVID-19: another piece of the puzzle |
Nicola Farina, Lorenzo Dagna |
| 100 |
[GO] |
2022―Apr―22 |
Effects of Non-Invasive Respiratory Supports on inspiratory effort in moderate-severe COVID-19 patients. A randomized physiological study. |
Gioacchino Schifino, Maria L Vega, Lara Pisani, Irene Prediletto, Vito Catalanotti, Vittoria Comellini, Ilaria Bassi, Maurizio Zompatori, Marco Vito Ranieri, Stefano Nava |
| 101 |
[GO] |
2022―Apr―14 |
Experience with procalcitonin use during the COVID-19 pandemic |
Laura Gonzalez, Thomas Holman, Daniel Waite, Pearl Abenojar |
| 102 |
[GO] |
2022―Apr―13 |
Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19 |
Rosaria Sofia, Mattias Carbone, Giovanni Landoni, Alberto Zangrillo, Lorenzo Dagna |
| 103 |
[GO] |
2022―Apr―07 |
Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials |
Panagiotis T. Tasoudis, Christina K. Arvaniti, Anastasia T. Adamou, Ioannis Belios, John H. Stone, Nora Horick, Dimitrios Sagris, George N. Dalekos, George Ntaios |
| 104 |
[GO] |
2022―Mar―16 |
The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients |
F. Calabretta, P.S. Preti, M. Russo, C. Klersy, A. Di Sabatino |
| 105 |
[GO] |
2022―Mar―14 |
Physical decline and cognitive impairment in frail hypertensive elders during COVID-19 |
Pasquale Mone, Antonella Pansini, Salvatore Frullone, Antonio de Donato, Veronica Buonincontri, Paolo De Blasiis, Anna Marro, Maria Morgante, Antonio De Luca, Gaetano Santulli |
| 106 |
[GO] |
2022―Mar―14 |
Doubtful clinical benefit of casirivimab-imdevimab treatment for disease severity outcome of high-risk patients with SARS-CoV-2 delta variant infection |
Noah Shopen, Michal Dekel, Michal Mizrahi, Efrat Zandberg, Daniel Talmud, Neta Cohen |
| 107 |
[GO] |
2022―Mar―11 |
The Precautionary Principle in the COVID-19 vaccination campaign: the complicated relationship between the scientific community, medicines regulatory agencies and citizens |
Lobello Paola Aurora, Squizzato Alessandro, Picozzi Mario |
| 108 |
[GO] |
2022―Mar―09 |
“Thrombotic events following Covid-19 vaccines compared to Influenza vaccines.” |
Marcelo Gabriel Vallone, Andre Luis Falcón, Horacio Matias Castro, Augusto Ferraris, Ramiro Francisco Cantarella, María Inés Staneloni, Valeria Ines Aliperti, Analia Ferloni, Daniela Mezzarobba, Fernando Javier Vázquez, María Florencia Grande Ratti |
| 109 |
[GO] |
2022―Feb―14 |
Double-gloving in an Intensive Care Unit during the COVID-19 pandemic |
Ori Galante, Abraham Borer, Yaniv Almog, Lior Fuchs, Lisa Saidel-Odes |
| 110 |
[GO] |
2022―Feb―14 |
Is the number of long-term post-COVID symptoms relevant in hospitalized COVID-19 survivors? |
César Fernández-de-las-Peñas, Umut Varol, Stella Fuensalida-Novo, Susana Plaza-Canteli, Juan Antonio Valera-Calero |
| 111 |
[GO] |
2022―Feb―14 |
Reduced COVID-19 mortality linked with early antibodies against SARS-CoV-2, irrespective of age |
Danila De Vito, Agostino Di Ciaula, Vincenzo O. Palmieri, Paolo Trerotoli, Angela Maria Vittoria Larocca, Maria Teresa Montagna, Piero Portincasa |
| 112 |
[GO] |
2022―Feb―03 |
Acute coronary syndromes during the first and the second wave of COVID-19 |
Marco Ferlini, Diego Castini, Luigi Oltrona Visconti, Stefano Carugo |
| 113 |
[GO] |
2022―Jan―31 |
Usefulness of non-invasive methods for the monitoring of oxygenation parameters in patients with COVID-19 associated ARDS |
Diego Alberto Pérez Pinzón, Cristin Camilo Villa Gómez, Julio Andrés Boada Garnica, Marlon Adrián Laguado Nieto |
| 114 |
[GO] |
2022―Jan―28 |
Pulmonary embolism severity and in-hospital mortality: An international comparative study between COVID-19 and non-COVID patients |
Òscar Miró, Sònia Jiménez, Pere Llorens, Melanie Roussel, Judith Gorlicki, Eric Jorge García-Lamberechts, Pierrick Le Borgne, Javier Jacob, Anthony Chauvin, Olivier Lucidarme, Guillermo Burillo-Putze, Alfons Aguirre, Fabien Brigant, Laura Lozano, Juan González del Castillo, Yonathan Freund |
| 115 |
[GO] |
2022―Jan―24 |
T-cell response to 3 doses of Sars-Cov2 BNT162b2 Pfizer vaccine in long term rituximab treated patients |
Jade Heitz, Jerome Razanamahery, Sylvain Audia, Jean-Baptiste Bour, Julien Guy, Sabine Berthier, Vanessa Leguy, Thibault Ghesquiere, Barbara Nicolas, Maxime Samson, Bernard Bonnotte |
| 116 |
[GO] |
2022―Jan―21 |
Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia. |
Jose F Varona, Elena Núñez, Borja M. Fernández Félix, Jose María Castellano Vázquez, Antonio Cubillo |
| 117 |
[GO] |
2022―Jan―12 |
COVID-19 Infection Survivors and the Risk of Depression and Anxiety Symptoms: A Nationwide Study of Adults in the United States |
Jagdish Khubchandani, James H. Price, Sushil Sharma, Fern J. Webb |
| 118 |
[GO] |
2022―Jan―10 |
Return to work after hospitalisation for COVID-19 infection |
Orlando Hürlimann, Pierre Decavel, Jean-Marie Annoni, Marco Mancinetti |
| 119 |
[GO] |
2022―Jan―07 |
Convalescent plasma for COVID-19. TSUNAMI is not the final word |
Massimo Franchini, Daniele Focosi, Arturo Casadevall, Michael J. Joyner, Cesare Perotti |
| 120 |
[GO] |
2022―Jan―05 |
SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure |
Jesús Fernando García-Cruces-Méndez, Luis Corral-Gudino, María Piedad Del-Amo-Merino, José María Eiros-Bouza, Marta Domínguez-Gil González |
| 121 |
[GO] |
2021―Dec―21 |
CORRELATION OF NON-INVASIVE OXYGENATION PARAMETERS WITH paO2/FiO2 RATIO IN PATIENTS WITH COVID-19 ASSOCIATED ARDS |
Giacomo Zaccagnini, Andrea Berni, Filippo Pieralli |
| 122 |
[GO] |
2021―Dec―21 |
The relevance of nutritional and metabolic derangements in COVID-19 patients |
Alessio Molfino, Giovanni Imbimbo, Maurizio Muscaritoli |
| 123 |
[GO] |
2021―Dec―07 |
Factors associated with persistence of symptoms 1 year after COVID-19: a longitudinal, prospective phone-based interview follow-up cohort study |
Carlo Fumagalli, Chiara Zocchi, Luigi Tassetti, Maria Vittoria Silverii, Carla Amato, Luca Livi, Lorenzo Giovannoni, Federica Verillo, Alessandro Bartoloni, Rossella Marcucci, Federico Lavorini, Stefano Fumagalli, Andrea Ungar, Iacopo Olivotto, Laura Rasero, Francesco Fattirolli, Niccolò Marchionni |
| 124 |
[GO] |
2021―Nov―29 |
Short term Blood Pressure Alterations in Recently COVID-19 Vaccinated Patients |
Elias Sanidas, Theoharis Anastasiou, Dimitrios Papadopoulos, Maria Velliou, Marina Mantzourani |
| 125 |
[GO] |
2021―Nov―25 |
Colchicine for the prevention of COVID-19 “hard” outcomes: all that glitters is not gold |
Dimitrios Patoulias, Christodoulos Papadopoulos, Asterios Karagiannis, Michael Doumas |
| 126 |
[GO] |
2021―Nov―22 |
Tocilizumab in severe COVID-19: A promise fulfilled |
Marcel Levi |
| 127 |
[GO] |
2021―Nov―13 |
Colchicine for COVID-19: hype or hope? |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 128 |
[GO] |
2021―Nov―12 |
Learning in times of stress: lessons from COVID-19 that will last throughout this century. |
Paula Jiménez-Fonseca, Ramón Salazar, Vicent Valentí, Alberto Carmona-Bayonas, Giancarlo Agnelli |
| 129 |
[GO] |
2021―Nov―11 |
Anakinra in COVID-19: A step closer to the cure |
Fotios Barkas, Eirini Christaki, Evangelos Liberopoulos, Maria Kosmidou, Haralampos Milionis |
| 130 |
[GO] |
2021―Nov―11 |
Anticoagulant therapy for COVID-19: What we have learned and what are the unanswered questions? |
Dimitrios Giannis, James D. Douketis, Alex C. Spyropoulos |
| 131 |
[GO] |
2021―Oct―29 |
Long COVID: A patient perspective |
S. Harari, L. Ripamonti, P. Marveggio, P.M. Mannucci |
| 132 |
[GO] |
2021―Oct―27 |
Hydroxichloroquine for COVID-19 infection: do we have a final word after one year? |
Dr. Augusto Di Castelnuovo, Simona Costanzo, Alessandro Gialluisi, Licia Iacoviello, Giovanni de Gaetano |
| 133 |
[GO] |
2021―Oct―27 |
Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose? |
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, Gil Harari, Michael Gurevich |
| 134 |
[GO] |
2021―Oct―25 |
One year later: The case of tocilizumab in COVID-19 |
Corrado Campochiaro, Alessandro Tomelleri, Marco Matucci-Cerinic, Lorenzo Dagna |
| 135 |
[GO] |
2021―Oct―25 |
Standardized PaO2/FiO2 ratio in COVID-19: added Added value or risky assumption. Author's reply |
Irene Prediletto, Stefano Nava, Paolo Palange |
| 136 |
[GO] |
2021―Oct―25 |
Predicting adverse outcomes in patients with COVID-19: just an epidemiological debate or a valuable clinical approach? |
Xavier Corbella |
| 137 |
[GO] |
2021―Oct―22 |
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply |
Emanuel Della-Torre, Marco Lanzillotta, Giuseppe Alvise Ramirez, Lorenzo Dagna, Moreno Tresoldi |
| 138 |
[GO] |
2021―Oct―19 |
COVID-19 vaccination and a severe pain in the neck |
Angelos Kyriacou, Stamatina Ioakim, Akheel A. Syed |
| 139 |
[GO] |
2021―Oct―15 |
Electrocardiographic Features of Patients with COVID-19: One Year of Unexpected Manifestations |
Fabio Angeli, Gianpaolo Reboldi, Antonio Spanevello, Roberto De Ponti, Dina Visca, Jacopo Marazzato, Martina Zappa, Monica Trapasso, Sergio Masnaghetti, Leonardo M. Fabbri, Paolo Verdecchia |
| 140 |
[GO] |
2021―Oct―12 |
Cardiopulmonary exercise test with stress echocardiography in COVID-19 survivors at 6 months follow-up |
Luca Vannini, Alejandro Quijada-Fumero, M Purificación Ramirez Martín, Nuria Castejón Pina, Julio S. Hernandez Afonso |
| 141 |
[GO] |
2021―Sep―24 |
Serum IgG4 level predicts COVID-19 related mortality |
Emanuel Della-Torre, Marco Lanzillotta, Marta Strollo, Giuseppe Alvise Ramirez, Lorenzo Dagna, Moreno Tresoldi |
| 142 |
[GO] |
2021―Sep―23 |
The coupling between sarcopenia and COVID-19 is the real problem |
Rizwan Qaisar, Asima Karim, Tahir Muhammad, Islam Shah, M. Shahid Iqbal |
| 143 |
[GO] |
2021―Sep―20 |
The Pivotal Link Between ACE2 Deficiency and SARS-CoV-2 Infection: One Year Later |
Fabio Angeli, Martina Zappa, Gianpaolo Reboldi, Monica Trapasso, Claudio Cavallini, Antonio Spanevello, Paolo Verdecchia |
| 144 |
[GO] |
2021―Sep―09 |
Standardised PaO2/FiO2 ratio in COVID-19: added value or risky assumptions? |
Luciano Gattinoni, Mattia Busana, Luigi Camporota |
| 145 |
[GO] |
2021―Sep―09 |
Vitamin D deficiency and inactivated SARS-CoV-2 vaccines |
Chia-Chao Wu, Kuo-Cheng Lu |
| 146 |
[GO] |
2021―Sep―02 |
Long term consequences of COVID-19 |
Anna Berenguera |
| 147 |
[GO] |
2021―Aug―30 |
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care. |
Lucia Taramasso, Laura Magnasco, Federica Portunato, Federica Briano, Antonio Vena, Daniele R. Giacobbe, Chiara Dentone, Chiara Robba, Lorenzo Ball, Maurizio Loconte, Nicolò Patroniti, Paolo Frisoni, Raffaele D'Angelo, Silvia Dettori, Malgorzata Mikulska, Paolo Pelosi, Matteo Bassetti |
| 148 |
[GO] |
2021―Aug―28 |
EXPLORING THE POSSIBLE LINK BETWEEN MYOCARDITIS AND mRNA COVID-19 VACCINES |
Gianfranco Sinagra, Marco Merlo, Aldostefano Porcari |
| 149 |
[GO] |
2021―Aug―25 |
One year on: the impact of COVID-19 on clinical research |
Luigi Tavazzi, Aldo P Maggioni, Claudio Rapezzi, Roberto Ferrari |
| 150 |
[GO] |
2021―Aug―16 |
SARCOPENIC OBESITY IS THE REAL PROBLEM IN COVID-19 ! |
Murat Kara, Ayşe Merve Ata, Levent Özçakar |
| 151 |
[GO] |
2021―Aug―16 |
Examination of the relationship between emergency department presentations and population mortality: a multicenter analysis of emergency department presentations during the COVID-19 pandemic |
Monica Solbiati, Lorenzo Russo, Anna Beverina, Paolo Groff, Andrea Strada, Ludovico Furlan, Nicola Montano, Giorgio Costantino, Giovanni Casazza |
| 152 |
[GO] |
2021―Aug―16 |
ChAdOx1 nCoV-19 EFFECTIVENESS DURING AN UNPRECEDENTED SURGE IN SARS COV-2 INFECTIONS |
Ruma Satwik, Ambarish Satwik, Satendra Katoch, Satish Saluja |
| 153 |
[GO] |
2021―Jul―10 |
Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) |
Jose F. Varona, Millán García-Isidro, Mojdeh Moeinvaziri, María Ramos-López, Manuel Fernández-Domínguez |
| 154 |
[GO] |
2021―Jul―02 |
The link between nutritional status and outcomes in COVID-19 patients in ICU: Is obesity or sarcopenia the real problem? |
Alessio Molfino, Giovanni Imbimbo, Veronica Rizzo, Maurizio Muscaritoli, Daniela Alampi |
| 155 |
[GO] |
2021―Jun―29 |
Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against COVID-19 pandemic: what pathogenesis? |
Raimondo De Cristofaro, Maurizio Sanguinetti |
| 156 |
[GO] |
2021―Jun―24 |
Laryngotracheal aspiration test reduce the false negative rate in patients with suspected SARS-COV-2 pneumonia despite a negative nasopharyngeal swab |
Peiman Nazerian, Roberto M. Sacco, Monica Solbiati, Elena Targetti, Chiara Marta, Francesco Blasi, Giovanni Casazza, Maria Grazia Colao, Sara Tomassetti, Stefano Grifoni, Gian Maria Rossolini, Giorgio Costantino |
| 157 |
[GO] |
2021―Jun―18 |
Mask-off Policy in the Shadow of Emerging Variants of SARS-COV-2 |
Abdolrazagh Hashemi Shahraki, Majid Vahed, Mehdi Mirsaeidi |
| 158 |
[GO] |
2021―Jun―17 |
Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: a pilot prospective study |
Irene Prediletto, Letizia D Antoni, Paolo Carbonara, Federico Daniele, Roberto Dongilli, Roberto Flore, Angela Maria Grazia Pacilli, Lara Pisani, Corina Tomsa, María Laura Vega, Vito Marco Ranieri, Stefano Nava, Paolo Palange |
| 159 |
[GO] |
2021―Jun―16 |
Prevalence of Post-COVID-19 Symptoms in Hospitalized and Non-Hospitalized COVID-19 Survivors: A Systematic Review and Meta-Analysis |
César Fernández-de-las-Peñas, Domingo Palacios-Ceña, Víctor Gómez-Mayordomo, Lidiane L Florencio, María L. Cuadrado, Gustavo Plaza-Manzano, Marcos Navarro-Santana |
| 160 |
[GO] |
2021―Jun―16 |
Blood Pressure Increase After Pfizer/BioNTech SARS-CoV-2 Vaccine: Pfizer/BioNTech SARS-CoV-2 Vaccine and Blood Pressure |
Martina Zappa, Paolo Verdecchia, Antonio Spanevello, Dina Visca, Fabio Angeli |
| 161 |
[GO] |
2021―Jun―12 |
LUNG ULTRASOUND IN COVID-19: INSIGHTS FROM THE FRONTLINE AND RESEARCH EXPERIENCES |
Chiara Cogliati, Frank Bosch, Yale Tung-Chen, Nick Smallwood, Juan Torres-Macho |
| 162 |
[GO] |
2021―Jun―05 |
Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma |
Dimitrios Patoulias, Athina Dimosiari, Theodoros Michailidis |
| 163 |
[GO] |
2021―May―25 |
Thrombosis with Thrombocytopenia Syndrome associated with viral vector COVID-19 vaccines |
Marco Cattaneo |
| 164 |
[GO] |
2021―May―25 |
SARS-CoV-2 vaccine-induced cerebral venous thrombosis |
Alfonso Ciccone |
| 165 |
[GO] |
2021―May―18 |
SARS-CoV-2 Antibody Kinetics Eight Months from COVID-19 Οnset: Persistence of Spike Antibodies but Loss of Neutralizing Antibodies in 24% of Convalescent Plasma Donors |
Evangelos Terpos, Dimitris Stellas, Margherita Rosati, Theodoros N. Sergentanis, Xintao Hu, Marianna Politou, Vassiliki Pappa, Ioannis Ntanasis-Stathopoulos, Sevasti Karaliota, Jenifer Bear, Duncan Donohue, Maria Pagoni, Elisavet Grouzi, Eleni Korompoki, George N. Pavlakis, Barbara K. Felber, Meletios A. Dimopoulos |
| 166 |
[GO] |
2021―May―14 |
Incident atrial fibrillation and its risk prediction in patients developing COVID-19:A machine learning based algorithm approachs |
Gregory Y.H. Lip, Ash Genaidy, George Tran, Patricia Marroquin, Cara Estes |
| 167 |
[GO] |
2021―Apr―30 |
Convalescent plasma in the management of COVID-19 pneumonia |
Ayman Elbadawi, Mina Shnoda, Maryrose Laguio-Vila, Mamas A. Mamas, Islam Y. Elgendy |
| 168 |
[GO] |
2021―Apr―30 |
Healthcare students: should they be prioritized for COVID-19 vaccination? |
Michele Augusto Riva, Maria Emilia Paladino, Michael Belingheri |
| 169 |
[GO] |
2021―Apr―30 |
SARS-CoV-2 Vaccines: Lights and Shadows |
Fabio Angeli, Antonio Spanevello, Gianpaolo Reboldi, Dina Visca, Paolo Verdecchia |
| 170 |
[GO] |
2021―Apr―20 |
Joint Effect of Heart Failure and Coronary Artery Disease on the Risk of Death during Hospitalization for COVID-19 |
Fabio Angeli, Jacopo Marazzato, Paolo Verdecchia, Antonella Balestrino, Claudio Bruschi, Piero Ceriana, Luca Chiovato, Laura Adelaide Dalla Vecchia, Roberto De Ponti, Francesco Fanfulla, Maria Teresa La Rovere, Francesca Perego, Simonetta Scalvini, Antonio Spanevello, Egidio Traversi, Dina Visca, Michele Vitacca, Tiziana Bachetti |
| 171 |
[GO] |
2021―Apr―08 |
Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients |
Guillaume Reichert, Vincent Bunel, Dora Dreyfuss, Loukbi Saker, Antoine Khalil, Hervé Mal |
| 172 |
[GO] |
2021―Apr―02 |
nObesity as an Adipose tissue dysfunction disease and A Risk Factor for Infections - Covid-19 as a case study |
Landecho MF, Marin-Oto M, Recalde-Zamacona B, Bilbao I, Gema Frühbeck |
| 173 |
[GO] |
2021―Mar―27 |
Lessons from pathophysiology: Use of individualized combination treatments with immune interventional agents to tackle severe respiratory failure in patients with COVID-19 |
George N. Dalekos, Aggelos Stefos, Sarah Georgiadou, Vasiliki Lygoura, Anastasia Michail, George Ntaios, Anna Samakidou, George Giannoulis, Stella Gabeta, Marianna Vlychou, Efthymia Petinaki, Konstantinos Leventogiannis, Evangelos J. Giamarellos-Bourboulis, Nikolaos K. Gatselis |
| 174 |
[GO] |
2021―Mar―27 |
Intermediate Dose Thromboprophylaxis in SARS-CoV-2 related Venous Thrombo Embolism |
Zahra Haider, Kanendran Rajalingam, Tanveer Khalid, Dilip Oswal, Akshay Dwarakanath |
| 175 |
[GO] |
2021―Mar―20 |
The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated |
Philipp Sprengholz, Sarah Eitze, Lars Korn, Regina Siegers, Cornelia Betsch |
| 176 |
[GO] |
2021―Mar―20 |
Pneumothorax/pneumomediastinum in non-intubated COVID-19 patients: differences between first and second Italian pandemic wave |
Diego Palumbo, Corrado Campochiaro, Alessandro Belletti, Alessandro Marinosci, Lorenzo Dagna, Alberto Zangrillo, Francesco De Cobelli |
| 177 |
[GO] |
2021―Mar―20 |
Pre-admission atrial fibrillation in COVID-19 patients: prevalence and clinical impact |
Vincenzo Russo, Angelo Silverio, Fernando Scudiero, Pierpaolo Di Micco, Marco Di Maio |
| 178 |
[GO] |
2021―Mar―20 |
When Is It Reasonable to Extrapolate During a Pandemic?: The Case of Broad UK Labeling for AstraZeneca COVID-19 Vaccine |
Rafael Dal-Ré, Rita Banzi |
| 179 |
[GO] |
2021―Mar―14 |
Loneliness that destroys and upsets: a lesson from and beyond COVID-19 |
Christian Bracco, Remo Melchio, Elena Migliore, Chiara Marrale, Luigi Fenoglio |
| 180 |
[GO] |
2021―Mar―07 |
USEFULNESS OF STEP DOWN UNITS TO MANAGE SURVIVORS OF CRITICAL COVID-19 PATIENTS |
Piero Ceriana, Michele Vitacca, Mara Paneroni, Stefano Belli, Nicolino Ambrosino |
| 181 |
[GO] |
2021―Feb―26 |
DNA genotyping of the ABO gene showed a significant association of the A-group (A1/A2 variants) with severe COVID-19. |
Juan Gómez, Guillermo M Albaiceta, Marta García-Clemente, José M. García-Gala, Eliecer Coto |
| 182 |
[GO] |
2021―Feb―26 |
Mid-term Prognostic Implication of hospitalized COVID-19 patients with Prior Heart Failure diagnosis |
Pau Llàcer, Luis Manzano, Cristina Fernández, Mari Carmen Moreno, Julio Núñez |
| 183 |
[GO] |
2021―Feb―26 |
Non-invasive respiratory support in the treatment of acute hypoxemic respiratory failure secondary to CoViD-19 related pneumonia |
Paolo Groff, Rodolfo Ferrari |
| 184 |
[GO] |
2021―Feb―15 |
DIAGNOSIS OF INFECTION BY SARS-COV-2: IS ONE MOLECULAR TEST ENOUGH? |
Antonella Mencacci, Maria Cristina Vedovati, Barbara Camilloni, Elio Cenci, Cecilia Becattini |
| 185 |
[GO] |
2021―Feb―06 |
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies. |
Laura Pasin, Giulio Cavalli, Paolo Navalesi, Nicolò Sella, Giovanni Landoni, Andrey G. Yavorovskiy, Valery V. Likhvantsev, Alberto Zangrillo, Lorenzo Dagna, Giacomo Monti |
| 186 |
[GO] |
2021―Feb―05 |
“Let me choose my COVID-19 vaccine” |
Rafael Dal-Ré, Richard Stephens, Nadarajah Sreeharan |
| 187 |
[GO] |
2021―Feb―05 |
SARS-CoV-2 seroprevalence in the Vatican City State |
Massimo Ralli, Andrea Arcangeli, Paolo Maurizio Soave, Cristina Voglino, Fabio De-Giorgio |
| 188 |
[GO] |
2021―Jan―31 |
Assessing the Impact of Covid-19 on the Health of Geriatric Patients: the European GeroCovid Observational Study |
Caterina Trevisan, Susanna Del Signore, Stefano Fumagalli, Pietro Gareri, Alba Malara, Enrico Mossello, Stefano Volpato, Fabio Monzani, Alessandra Coin, Giuseppe Bellelli, Gianluca Zia, Anette Hylen Ranhoff, Raffaele Antonelli Incalzi |
| 189 |
[GO] |
2021―Jan―22 |
A systematic bias assessment of top-cited full-length original clinical investigations related to COVID-19 |
Islam Y. Elgendy, Nayef Nimri, Amr F. Barakat, Joseph Ibrahim, John Mandrola, Andrew Foy |
| 190 |
[GO] |
2021―Jan―02 |
Lung ultrasonography: a prognostic tool in non-ICU hospitalized patients with COVID-19 pneumonia. |
Casella Francesco, Barchiesi Marco, Leidi Federica, Russo Giulia, Casazza Giovanni, Valerio Giulia, Torzillo Daniela, Ceriani Elisa, Del Medico Marta, Brambilla Anna Maria, Mazziotti Maria Alessandra, Cogliati Chiara |
| 191 |
[GO] |
2021―Jan―01 |
Flying higher than politics: the goal of preventive medicine at the time of the COVID-19 pandemic |
Francesco M. Galassi, Michael E. Habicht, F. Donald Pate, Elena Varotto |
| 192 |
[GO] |
2020―Dec―29 |
Low influenza vaccination coverage among hospitalized COVID-19 patients in Milan: a gap to be urgently filled. |
Anna Lisa Ridolfo, Laura Milazzo, Andrea Giacomelli, Letizia Oreni, Catia Borriello, Spinello Antinori |
| 193 |
[GO] |
2020―Dec―21 |
NEWS2 is a valuable tool for appropriate clinical management of COVID-19 patients |
Marta Rigoni, Emanuele Torri, Giandomenico Nollo, Livia Delle Donne, Susanna Cozzio |
| 194 |
[GO] |
2020―Nov―30 |
How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. |
Annemieke Smorenberg, Edgar JG Peters, Paul LA van Daele, Esther J Nossent, Majon Muller |
| 195 |
[GO] |
2020―Nov―23 |
Hydroxychloroquine for COVID-19: Balancing contrasting claims |
Peter W. Horby, Jonathan Emberson |
| 196 |
[GO] |
2020―Nov―12 |
The COVID-19 burden for health care professionals: Results of a global survey |
Matthias Schneider, Martin Altersberger, Christina Binder, Christian Hengstenberg, Thomas Binder |
| 197 |
[GO] |
2020―Nov―09 |
End-Stage renal disease and 30-day mortality for adults with and without COVID-19 |
Stephanie L. Harrison, Benjamin J.R. Buckley, Elnara Fazio-Eynullayeva, Paula Underhill, Deirdre A. Lane, Gregory Y.H. Lip |
| 198 |
[GO] |
2020―Nov―03 |
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 |
Marcello Di Nisio, Nicola Potere, Matteo Candeloro, Antonella Spacone, Leonardo Pieramati, Giovanna Ferrandu, Giulia Rizzo, Matteo La Vella, Silvio Di Carlo, Donatella Cibelli, Giustino Parruti, Marcel Levi, Ettore Porreca |
| 199 |
[GO] |
2020―Oct―31 |
Temporal changes in co-morbidities and mortality in patients hospitalized for COVID-19 in Italy |
Fabio Angeli, Tiziana Bachetti |
| 200 |
[GO] |
2020―Oct―28 |
Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness |
Giulio Cavalli, Lorenzo Dagna |
| 201 |
[GO] |
2020―Oct―23 |
Venous thromboembolism and COVID-19: mind the gap between clinical epidemiology and patient management |
Michela Giustozzi, Maria Cristina Vedovati, Giancarlo Agnelli |
| 202 |
[GO] |
2020―Oct―16 |
Does Hydroxychloroquine Reduce Mortality for COVID-19? |
Silvano GALLUS, Antonio CLAVENNA, Alessandra LUGO |
| 203 |
[GO] |
2020―Oct―15 |
DISEASE COURSE IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES: INSIGHTS ON THE SAFETY OF IMMUNOSUPPRESSION DURING THE SARS-COV-2 OUTBREAK IN ITALY |
Benfaremo Devis, Perini Lucia, Marconi Valentina, Luchetti Michele Maria, Gabrielli Armando |
| 204 |
[GO] |
2020―Oct―06 |
Significant increase in the incidence of high-risk pulmonary embolism during the COVID-19 shutdown: The pandemic response causes serious collateral consequences |
Paul Gressenberger, Thomas Gary, Reinhard B. Raggam, Andrea Borenich, Marianne Brodmann |
| 205 |
[GO] |
2020―Sep―25 |
Change over time of COVID-19 hospital presentation in Northern Italy |
Giuseppe Patti, Marco Mennuni, Francesco Della Corte, Enrico Spinoni, Pier Paolo Sainaghi |
| 206 |
[GO] |
2020―Sep―22 |
COVID-19 randomized controlled trials in medRxiv and PubMed |
Yuki Kataoka, Shiho Oide, Takashi Ariie, Yasushi Tsujimoto, Toshi A. Furukawa |
| 207 |
[GO] |
2020―Sep―17 |
Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. |
Loris Roncon, Marco Zuin, Stefano Barco, Luca Valerio, Giovanni Zuliani, Pietro Zonzin, Stavros V Konstantinides |
| 208 |
[GO] |
2020―Aug―25 |
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study |
Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, Nausicaa Berselli, Lorenzo Blandi, Raffaele Bruno, Roberto Cauda, Giovanni Guaraldi, Lorenzo Menicanti, Ilaria My, Giustino Parruti, Giuseppe Patti, Stefano Perlini, Francesca Santilli, Carlo Signorelli, Enrico Spinoni, Giulio G. Stefanini, Alessandra Vergori, Walter Ageno, Antonella Agodi, Luca Aiello, Piergiuseppe Agostoni, Samir Al Moghazi, Marinella Astuto, Filippo Aucella, Greta Barbieri, Alessandro Bartoloni, Marialaura Bonaccio, Paolo Bonfanti, Francesco Cacciatore, Lucia Caiano, Francesco Cannata, Laura Carrozzi, Antonio Cascio, Arturo Ciccullo, Antonella Cingolani, Francesco Cipollone, Claudia Colomba, Francesca Crosta, Chiara Dal Pra, Gian Battista Danzi, Damiano D'Ardes, Katleen de Gaetano Donati, Paola Del Giacomo, Francesco Di Gennaro, Giuseppe Di Tano, Giampiero D'Offizi, Tommaso Filippini, Francesco Maria Fusco, Ivan Gentile, Alessandro Gialluisi, Giancarlo Gini, Elvira Grandone, Leonardo Grisafi, Gabriella Guarnieri, Silvia Lamonica, Francesco Landi, Armando Leone, Gloria Maccagni, Sandro Maccarella, Andrea Madaro, Massimo Mapelli, Riccardo Maragna, Lorenzo Marra, Giulio Maresca, Claudia Marotta, Franco Mastroianni, Maria Mazzitelli, Alessandro Mengozzi, Francesco Menichetti, Marianna Meschiari, Filippo Minutolo, Arturo Montineri, Roberta Mussinelli, Cristina Mussini, Maria Musso, Anna Odone, Marco Olivieri, Emanuela Pasi, Francesco Petri, Biagio Pinchera, Carlo A. Pivato, Venerino Poletti, Claudia Ravaglia, Massimo Rinaldi, Andrea Rognoni, Marco Rossato, Ilaria Rossi, Marianna Rossi, Anna Sabena, Francesco Salinaro, Vincenzo Sangiovanni, Carlo Sanrocco, Laura Scorzolini, Raffaella Sgariglia, Paola Giustina Simeone, Michele Spinicci, Enrico Maria Trecarichi, Amedeo Venezia, Giovanni Veronesi, Roberto Vettor, Andrea Vianello, Marco Vinceti, Laura Vocciante, Raffaele De Caterina, Licia Iacoviello |
| 209 |
[GO] |
2020―Aug―13 |
Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: new case reports coming out |
Lucia De Franceschi, Enrico Costa, Francesco Dima, Matteo Morandi, Oliviero Olivieri |
| 210 |
[GO] |
2020―Jul―21 |
COVID-19 and hydroxychloroquine: Let the available data speak for themselves |
Ugo Paliani, Andrea Cardona |
| 211 |
[GO] |
2020―Jul―21 |
Italian Vò municipality cohort and COVID-19 epidemiology: The “Framingham” study of the 21st century |
Marco Zuin, Claudio Bilato, Giovanni Zuliani, Loris Roncon |
| 212 |
[GO] |
2020―Jul―09 |
Published evidence on COVID-19 in top-ranked journals: A descriptive study |
Juan M Pericàs, Andrea Arenas, Orla Torrallardona-Murphy, Helena Valero, David Nicolás |
| 213 |
[GO] |
2020―Jul―07 |
Romeo and Juliet: Revisited (at the time of COVID-19) |
Giorgio Costantino, Flora Peyvandi, Nicola Montano, Carlo Agostoni |
| 214 |
[GO] |
2020―Jul―07 |
Waste in COVID-19 clinical trials conducted in western Europe |
Rafael Dal-Ré, Ignacio Mahillo-Fernández |
| 215 |
[GO] |
2020―Jul―07 |
Linking hydroxychloroquine to hemolysis in a ‘suspected’ glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal |
T.P. Afra, Ram Vasudevan Nampoothiri, Muhammed Razmi T, N. A. Bishurul Hafi |
| 216 |
[GO] |
2020―Jun―28 |
First comes the A, then the B: what we learned from the COVID-19 outbreak |
Roberto Copetti, Giulia Amore, Carmine Cristiano Di Gioia, Daniele Orso |
| 217 |
[GO] |
2020―Jun―23 |
Chloroquine and COVID-19: A western medical and scientific drift? |
Matthieu Million, Yanis Roussel, Didier Raoult |
| 218 |
[GO] |
2020―Jun―20 |
Electrocardiographic features of patients with COVID-19 pneumonia |
Fabio Angeli, Antonio Spanevello, Roberto De Ponti, Dina Visca, Jacopo Marazzato, Giulia Palmiotto, Davide Feci, Gianpaolo Reboldi, Leonardo M. Fabbri, Paolo Verdecchia |
| 219 |
[GO] |
2020―Jun―13 |
No double-edged sword and no doubt about the relation between smoking and COVID-19 severity |
Silvano GALLUS, Alessandra LUGO, Giuseppe GORINI |
| 220 |
[GO] |
2020―Jun―12 |
Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association? |
Alessandro Giollo, Giovanni Cioffi, Maurizio Rossini, Ombretta Viapiana, Giovanni De Simone |
| 221 |
[GO] |
2020―Jun―10 |
Management and outcomes of post-acute COVID-19 patients in Northern Italy |
Michele Vitacca, Giovanni Battista Migliori, Antonio Spanevello, Mario Giovanni Melazzini, Nicolino Ambrosino |
| 222 |
[GO] |
2020―Jun―09 |
SARS-CoV-2 infection among asymptomatic homebound subjects in Milan, Italy |
Gregorio Paolo Milani, Emanuele Montomoli, Valentina Bollati, Benedetta Albetti, Claudio Bandi, Tommaso Bellini, Matteo Bonzini, Marco Buscaglia, Carlo Cantarella, Laura Cantone, Michele Carugno, Sergio Casartelli, Guido Cavaletti, Sarah D'Alessandro, Francesca De Chiara, Serena Delbue, Laura Dioni, Ivano Eberini, Chiara Favero, Luca Ferrari, Monica Ferraroni, Laura Galastri, Cristina Galli, Mirjam Hoxha, Simona Iodice, Carlo La Vecchia, Chiara Macchi, Ilaria Manini, Serena Marchi, Jacopo Mariani, Elena Pariani, Angela Cecilia Pesatori, Federica Rota, Massimiliano Ruscica, Tommaso Schioppo, Letizia Tarantini, Claudia Maria Trombetta, Maria Grazia Valsecchi, Marco Vicenzi, Giuliano Zanchetta |
| 223 |
[GO] |
2020―Jun―07 |
Need for innovative and timely synthesis of evidence during Covid-19 outbreak |
Giulio Francesco Romiti, Bernadette Corica, Roberto Cangemi, Stefania Basili, Valeria Raparelli |
| 224 |
[GO] |
2020―Jun―06 |
PROTECTIVE ROLE OF CHRONIC TREATMENT WITH DIRECT ORAL ANTICOAGULANTS IN ELDERLY PATIENTS AFFECTED BY INTERSTITIAL PNEUMONIA IN COVID-19 ERA |
Rosario Rossi, Francesca Coppi, Marisa Talarico, Giuseppe Boriani |
| 225 |
[GO] |
2020―Jun―05 |
COVID-19, a viral endocrinological disease? |
Tiziana Grassi, Elena Varotto, Francesco M. Galassi |
| 226 |
[GO] |
2020―Jun―04 |
COVID-19 and hydroxychloroquine: is the wonder drug failing? |
Ugo Paliani, Andrea Cardona |
| 227 |
[GO] |
2020―Jun―02 |
COVID-19: The Waterloo of governments, healthcare systems, and large health organizations. |
Michael Doumas, Konstantinos P. Imprialos, Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Stavropoulos |
| 228 |
[GO] |
2020―Jun―01 |
Hepatic consequences of COVID-19 infection. Lapping or biting? |
Piero Portincasa, Marcin Krawczyk, Antonia Machill, Frank Lammert, Agostino Di Ciaula |
| 229 |
[GO] |
2020―May―28 |
Active smoking and severity of coronavirus disease 2019 (COVID-19): Differences in measurement of variables could cause errors in the results. |
Sánchez JJ, Acevedo N, Guzmán E |
| 230 |
[GO] |
2020―May―28 |
Covid-19 in Italy: lesson from the Veneto Region |
Giacomo Mugnai, Claudio Bilato |
| 231 |
[GO] |
2020―May―28 |
Balancing the need for rapid and rigorous scientific data during early phase of the COVID-19 pandemic: A further role for the scientific community |
Mario Rotondi, Manuel Nieto-Diaz, Flavia Magri, Antonio Oliviero |
| 232 |
[GO] |
2020―May―28 |
The eighth alternative to Evidence Based Medicine in the early era of the COVID-19 pandemic: too much Emergency and Emotion, too little Evidence. |
Filippo Pieralli, Vieri Vannucchi, Iacopo Olivotto |
| 233 |
[GO] |
2020―May―28 |
Does active smoking worsen Covid-19? |
Alberto Carmona Bayonas, Paula Jimenez-Fonseca, Álvaro Sánchez Arraez, Felipe Álvarez Manceñido, Eduardo Castañón |
| 234 |
[GO] |
2020―May―22 |
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study |
Corrado Campochiaro, Emanuel Della-Torre, Giulio Cavalli, Giacomo De Luca, Marco Ripa, Nicola Boffini, Alessandro Tomelleri, Elena Baldissera, Patrizia Rovere-Querini, Annalisa Ruggeri, Giacomo Monti, Francesco De Cobelli, Alberto Zangrillo, Moreno Tresoldi, Antonella Castagna, Lorenzo Dagna |
| 235 |
[GO] |
2020―May―21 |
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy |
Valentina Morena, Laura Milazzo, Letizia Oreni, Giovanna Bestetti, Tommaso Fossali, Cinzia Bassoli, Alessandro Torre, Maria Vittoria Cossu, Caterina Minari, Elisabetta Ballone, Andrea Perotti, Davide Mileto, Fosca Niero, Stefania Merli, Antonella Foschi, Stefania Vimercati, Giuliano Rizzardini, Salvatore Sollima, Lucia Bradanini, Laura Galimberti, Riccardo Colombo, Valeria Micheli, Cristina Negri, Anna Lisa Ridolfo, Luca Meroni, Massimo Galli, Spinello Antinori, Mario Corbellino |
| 236 |
[GO] |
2020―May―16 |
Tocilizumab for severe COVID-19: a promising intervention affecting inflammation and coagulation |
Marcel Levi |
| 237 |
[GO] |
2020―May―16 |
Why should we use convalescent plasma for COVID-19? |
Massimo Franchini |
| 238 |
[GO] |
2020―May―15 |
Good times, bad times: A diary of a physician in the COVID-19 era |
Tommaso Lupia, Giacomo Stroffolini, Roberto Angilletta, Stefano Bonora, Giovanni Di Perri |
| 239 |
[GO] |
2020―May―13 |
Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia |
Ruggero Capra, Nicola De Rossi, Flavia Mattioli, Giuseppe Romanelli, Cristina Scarpazza, Maria Pia Sormani, Stefania Cossi |
| 240 |
[GO] |
2020―May―08 |
Active smoking and severity of coronavirus disease 2019 (COVID-19): the use of significance testing leads to an erroneous conclusion |
Ernest Lo, Benoit Lasnier |
| 241 |
[GO] |
2020―May―07 |
Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern? |
Clara Benedetta Conti, Sonia Henchi, Giovanni Paolo Coppeta, Sophie Testa, Roberto Grassia |
| 242 |
[GO] |
2020―May―03 |
Do we know when to end isolation of persons affected with COVID-19? |
Dror Dicker, Tatiana Kournos, Dana Marcoviciu, Rachel Golan |
| 243 |
[GO] |
2020―May―01 |
Active smoking and COVID-19: a double-edged sword |
Giuseppe Lippi, Fabian Sanchis-Gomar, Brandon Michael Henry |
| 244 |
[GO] |
2020―Apr―30 |
Covid-19 cases in a no-Covid-19 geriatric acute care setting. A sporadic occurrence? |
Stefano Fumagalli, Bernardo Salani, Luciano Gabbani, Enrico Mossello, Andrea Ungar |
| 245 |
[GO] |
2020―Apr―30 |
The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed |
Paul H. Lee |
| 246 |
[GO] |
2020―Apr―23 |
Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data |
Paulo Ricardo Martins-Filho, Carolina Santos Souza Tavares, Victor Santana Santos |
| 247 |
[GO] |
2020―Apr―23 |
Smoking habit and hospitalization for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related pneumonia: The unsolved paradox behind the evidence. |
Giovanna Garufi, Luisa Carbognin, Armando Orlandi, Giampaolo Tortora, Emilio Bria |
| 248 |
[GO] |
2020―Apr―23 |
SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade |
Andrea Farina, Giuseppe Uccello, Marta Spreafico, Giorgio Bassanelli, Stefano Savonitto |
| 249 |
[GO] |
2020―Apr―20 |
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection |
Paolo Verdecchia, Claudio Cavallini, Antonio Spanevello, Fabio Angeli |
| 250 |
[GO] |
2020―Apr―13 |
COVID-19: TIMING IS IMPORTANT |
Giovanni de Simone, Costantino Mancusi |
| 251 |
[GO] |
2020―Apr―08 |
Is low sodium intake a risk factor for severe and fatal COVID-19 infection? |
Adrian Post, Robin P.F. Dullaart, Stephan J.L. Bakker |
| 252 |
[GO] |
2020―Mar―16 |
Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19) |
Giuseppe Lippi, Brandon Michael Henry |
